The gasotransmitter hydrogen sulfide in hemodialysis patients

Journal of Nephrology

Volumn 23, Issue SUPPL.16, 2010, Pages

  Perna, Alessandra F ^a   Sepe, Immacolata ^a   Lanza, Diana ^a   Capasso, Rosanna ^a   Di Marino, Veronica ^a   De Santo, Natale G ^a   Ingrosso, Diego ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cystathionine lyase; Hemodialysis; Hydrogen sulfide; Sulfidric acid

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HYDROGEN SULFIDE;

ANIMAL; CARDIOVASCULAR DISEASE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; CYSTATHIONINE BETA-SYNTHASE; HUMANS; HYDROGEN SULFIDE; RENAL DIALYSIS;

EID: 79952284191     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem. 2010;113:14-26.
2. Wang R. Toxic gas, lifesaver. Sci Am. 2010;302:50-55.
3. Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008;322:587-590.
4. Mathai JC, Missner A, Kugler P, et al. No facilitator required for membrane transport of hydrogen sulfide. Proc Natl Acad Sci U S A. 2009;106:16633-16638.
5. Mustafa AK, Gadalla MM, Sen N, et al. H2S signals through protein S-sulfhydration. Sci Signal. 2009;2:ra72.
6. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med. 2009;13:488-507.
7. Chen X, Jhee K, Kruger WD. Production of the neuromodulator H2S by cystathionine ß-synthase via the condensation of cysteine and homocysteine. J Biol Chem. 2004;279:52082-52086.
8. Chiku T, Padovani D, Zhu W, Singh S, Vitvitsky V, Banerjee R. H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem. 2009;284:11601-11612.
9. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem. 2009;146:623-626.
10. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids. 2010 Feb 27. DOI:10.1007/s00726- 010-0510-x [Epub ahead of print].
11. Benavides GA, Squadrito GL, Mills RW, et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A. 2007;104:17977-17982.
12. Budoff MJ, Ahmadi N, Gul KM, et al. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med. 2009;49:101-107.
13. Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A. 2007;104:15560-15565.
14. Sen U, Vacek TP, Hughes WM, et al. Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation. Pharmacology. 2008;82:201-213.
15. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun. 2004;313:22-27.
16. Zhao W, Zhang J, Lu Y, et al. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J. 2001;20:6008-6016.
17. Jiang HL, Wu HC, Li ZL, Geng B, Tang CS. Changes of the new gaseous transmitter H2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Bao. 2005;25:951-954.
18. Li C, Sumou I, Ya-guang D, et al. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J. 2007;120:389-393.
19. Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2008;29:173-179.
20. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693-1699.
21. Perna AF, Ingrosso D, De Santo NG, et al. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int. 1995;47:247-253.
22. Perna AF, Ingrosso D, Violetti E, et al. Hyperhomocysteinemia in uremia: a red flag in a disrupted circuit. Semin Dial. 2009;22:351-356.
23. Perna AF, Luciano MG, Ingrosso D, et al. Hydrogen sulphide- generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant. 2009;24:3756-3763.
24. Lefer DJ. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci U S A. 2007;104:17907-17908.
25. Hasuike Y, Nakanishi T, Moriguchi R, et al. Accumulation of cyanide and thiocyanate in hemodialysis patients. Nephrol Dial Transplant. 2004;19:1474-1479.
26. D'Emanuele di Villa Bianca R, Sorrentino R, Maffia P, et al. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc Natl Acad Sci U S A. 2009;106:4513-4518.
27. Sen U, Basu P, Abe OA, et al. Hydrogen sulfide ameliorates hyperhomocysteinemia associated chronic renal failure. Am J Physiol Renal Physiol. 2009;297:F410-F419.
28. Lu M, Liu Y, Goh HS, et al. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol. 2010;21:993-1002.